CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-01 | Teplitsky Liane Rae Chief Operating Officer | Purchase | +1,001 | $49.95 | $50K | 4,095 |
| 2026-08-31 | Teplitsky Liane Rae Chief Operating Officer | Purchase | +1,024 | $48.80 | $50K | 3,094 |
| 2026-08-28 | Teplitsky Liane Rae Chief Operating Officer | Purchase | +1,034 | $48.35 | $50K | 2,070 |
| 2026-08-26 | Teplitsky Liane Rae Chief Operating Officer | Purchase | +1,036 | $48.24 | $50K | 1,036 |
| 2026-08-08 | Teplitsky Liane Rae Chief Operating Officer | Grant or award · Restricted Stock Units | +200,000 | 200,000 | ||
| 2026-08-08 | Teplitsky Liane Rae Chief Operating Officer | Grant or award · Stock Option (right to buy) | +700,000 | 700,000 | ||
| 2026-06-11 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-11 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +14,504 | 14,504 | ||
| 2026-06-11 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-11 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +8,423 | 8,423 | ||
| 2026-06-11 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-11 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +12,495 | 12,495 | ||
| 2026-06-11 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-11 | Sainz Maria Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-11 | Sainz Maria Director | Grant or award · Stock Option (right to buy) | +3,793 | 3,793 | ||
| 2026-05-11 | DUGGAN ROBERT W Director | Purchase | +660,233 | $19.69 | $13.0M | 48,370,047 |
| 2026-05-11 | LAVIOLETTE PAUL A Chief Executive Officer | Purchase | +15,000 | $19.69 | $295K | 15,846 |
| 2026-05-11 | LAVIOLETTE PAUL A Chief Executive Officer | Purchase | +15,000 | $19.69 | $295K | 15,000 |
| 2026-05-11 | DUGGAN ROBERT W Director | Purchase | +660,233 | $19.69 | $13.0M | 48,211,433 |
| 2026-03-23 | UECKER DARRIN Chief Technology Officer | Grant or award · Restricted Stock Units | +100,000 | 100,000 |
Page 1 of 15 · 292 trades